Table 2.

Results of single marker-based genetic association analyses

CHR	SNP	POS	A1	F_A	F_U	A2	χ2	P	OR[95% CI]
17	rs4453563	75674697	T	0.28	0.27	G	0.05	0.82	1.02[0.85–1.23]
17	rs8076675	75682774	T	0.16	0.16	C	0.10	0.75	1.04[0.83–1.30]
17	rs62090774	75682779	C	0.12	0.11	T	0.07	0.79	1.04[0.80–1.34]
17	rs2898569	75685840	T	0.41	0.41	A	0.01	0.91	1.01[0.85–1.19]
17	rs1661652	75687957	A	0.25	0.25	T	0.01	0.91	0.99[0.82–1.20]
17	rs4999137	75687959	A	0.38	0.38	T	0.03	0.86	0.99[0.83–1.17]
17	rs1661651	75687961	A	0.31	0.31	T	0.01	0.91	0.99[0.83–1.18]
17	rs2053508	75689579	G	0.43	0.42	A	0.07	0.79	1.02[0.87–1.21]
17	rs820218	75691415	A	0.11	0.15	G	9.49	0.0021	0.67[0.52–0.87]
17	rs62090776	75692348	T	0.07	0.06	G	0.47	0.50	1.12[0.80–1.58]
17	rs7208873	75696377	C	0.26	0.25	A	0.05	0.82	1.02[0.85–1.24]
17	rs3743999	75703466	C	0.16	0.15	G	0.13	0.71	1.04 [0.83–1.31]

CHR chromosome, SNP single nucleotide polymorphism, POS position; A1/A2: minor/major allele; F_A/F_U: minor allele frequency of the patients/controls.

A significant result is indicated in bold font. The statistical significance threshold of the P values was 0.05/12 ≈ 0.004.